TCW Group Inc. Buys 55,768 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

TCW Group Inc. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 10.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 589,120 shares of the company's stock after acquiring an additional 55,768 shares during the period. TCW Group Inc. owned about 0.13% of GE HealthCare Technologies worth $46,057,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in GEHC. D1 Capital Partners L.P. bought a new position in shares of GE HealthCare Technologies during the third quarter valued at $268,159,000. Van ECK Associates Corp increased its position in shares of GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock worth $378,520,000 after purchasing an additional 2,506,417 shares in the last quarter. State Street Corp lifted its holdings in GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after purchasing an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new position in GE HealthCare Technologies in the third quarter valued at about $93,713,000. Finally, Jennison Associates LLC grew its stake in GE HealthCare Technologies by 124.5% during the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company's stock worth $133,659,000 after buying an additional 948,017 shares during the last quarter. Institutional investors own 82.06% of the company's stock.

Remove Ads

GE HealthCare Technologies Trading Down 0.2 %

GE HealthCare Technologies stock traded down $0.14 during mid-day trading on Wednesday, hitting $90.67. The stock had a trading volume of 1,845,368 shares, compared to its average volume of 2,823,462. The stock has a 50-day simple moving average of $85.49 and a two-hundred day simple moving average of $86.01. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $41.46 billion, a PE ratio of 20.94, a P/E/G ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on GEHC. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Citigroup lifted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.